Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2023

Loss Per Share [Abstract]

Antidilutive Securities Excluded from Computation of Earnings Per Share

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

	March 31, 2023		March 31, 2022
	(shares)		(shares)
Warrants to purchase shares of common stock		11,757,964		10,857,964
Options to purchase shares of common stock		6,526,758		5,630,561
Shares of common stock issuable upon conversion of convertible notes payable – related party		5,966,437		5,365,259
Shares of common stock issuable upon conversion of convertible line of credit – related party		6,727,849		—
Shares of common stock issuable upon conversion of preferred stock		503,340		510,424
		31,482,348		22,364,208